Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903975 · ClinicalTrials.gov registry record · Phase 4
BoTox Into the Sternocleidomastoid Muscles (SCM)
A Phase 4 study of Neck Muscle Issue, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06903975 is a Phase 4 study of Neck Muscle Issue that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06903975, a Phase 4 study of Neck Muscle Issue, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.
Conditions Studied
Interventions
- DRUG prabotulinumtoxinA-xvfs
Study Locations (1)
Massachusetts
- The Spiegel Center - Newton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-05-14 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06903975
The ClinicalTrials.gov registry entry for NCT06903975 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neck Muscle Issue appearing as the primary indexed condition, and to 1 intervention - of which prabotulinumtoxinA-xvfs is the first listed.
NCT06903975 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06903975 about?
NCT06903975 is a clinical study titled "BoTox Into the Sternocleidomastoid Muscles (SCM)". Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimmi...
What is the current status of trial NCT06903975?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2025-05-14. Estimated completion is 2026-03.
What conditions does trial NCT06903975 study?
This clinical trial studies the following conditions: Neck Muscle Issue.
What interventions are being tested in trial NCT06903975?
The interventions under investigation include: prabotulinumtoxinA-xvfs (DRUG).
Who is sponsoring clinical trial NCT06903975?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903975 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.